Nedocromil
生产企业:King pharmaceuticals inc, Allergan inc,另有 1 家
Nedocromil is a pyrano quinoline used to treat allergic conjunctivitis.
Nedocromil is a pyrano quinoline used to treat allergic conjunctivitis.
Nedocromil has been shown to inhibit the in vitro activation of, and mediator release from, a variety of inflammatory cell types associated with asthma, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets. Nedocromil inhibits activation and release of inflammatory mediators such as histamine, prostaglandin D2 and leukotrienes c4 from different types of cells in the lumen and mucosa of the bronchial tree. These mediators are derived from arachidonic acid metabolism through the lipoxygenase and cyclo-oxygenase pathways. The mechanism of action of nedocromil may be due partly to inhibition of axon reflexes and release of sensory neuropeptides, such as substance P, neurokinin A, and calcitonin-geneñrelated peptides. The result is inhibition of bradykinin-induced bronchoconstriction. Nedocromil does not posess any bronchodilator, antihistamine, or corticosteroid activity.
用于预防性治疗各种原因诱发的哮喘和哮喘型慢性支气管炎。
共 3 项相关疾病
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。